Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
ZomedicaZOM |
$4.1M |
 |
Johnson & JohnsonJNJ |
-$104M |
 |
Mind Medicine (MindMed)MNMD |
-$45M |
 |
ModernaMRNA |
-$334B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Beaver Sandra | Sep 6, 2024 | Sell | 3,276 | $14.98 | $49,000 |
| Yamagishi-Dressler Tomoko | Aug 30, 2024 | Sell | 5,631 | $15.85 | $89,000 |
| MOATAZEDI DAVID | Jun 6, 2024 | Sell | 175,940 | $12.5866 | $2.2M |
| MOATAZEDI DAVID | Jun 5, 2024 | Sell | 155,278 | $12.9217 | $2M |
| MOATAZEDI DAVID | Jun 4, 2024 | Sell | 140,214 | $12.7283 | $1.8M |
| Malik Vikram | Jun 3, 2024 | Sell | 7,500 | $12.9604 | $97,000 |
| GILL DAVID N | May 14, 2024 | Sell | 6,718 | $12.601 | $85,000 |
| Malik Vikram | May 13, 2024 | Sell | 28,000 | $12.929 | $360,000 |
| GILL DAVID N | May 13, 2024 | Sell | 3,643 | $12.7247 | $46,000 |
| MOATAZEDI DAVID | May 10, 2024 | Sell | 16,051 | $12.7174 | $200,000 |
| Avelar Rui | May 10, 2024 | Sell | 3,441 | $12.7174 | $44,000 |
| Beaver Sandra | May 10, 2024 | Sell | 2,423 | $12.7174 | $31,000 |
| MOATAZEDI DAVID | Mar 27, 2024 | Sell | 6,236 | $13.86 | $86,000 |
| Avelar Rui | Mar 19, 2024 | Sell | 27,603 | $13.9242 | $380,000 |
| MOATAZEDI DAVID | Mar 19, 2024 | Sell | 96,566 | $13.9242 | $1.3M |
| Beaver Sandra | Mar 19, 2024 | Sell | 5,672 | $13.9242 | $79,000 |
| MOATAZEDI DAVID | Feb 22, 2024 | Sell | 7,706 | $13.0812 | $100,000 |
| Avelar Rui | Feb 22, 2024 | Sell | 1,821 | $13.0812 | $24,000 |
| Beaver Sandra | Feb 22, 2024 | Sell | 1,821 | $13.0812 | $24,000 |
| Parschauer Karah Herdman | Jan 30, 2024 | Sell | 11,931 | $13.1366 | $160,000 |
| MOATAZEDI DAVID | Dec 8, 2023 | Sell | 31,300 | $9.7286 | $300,000 |
| MOATAZEDI DAVID | Dec 6, 2023 | Sell | 51,348 | $10.0859 | $520,000 |
| Medytox Inc. | Oct 16, 2023 | Sell | 1,690,663 | $7.5 | $13M |
| Beaver Sandra | Sep 6, 2023 | Sell | 3,178 | $9.7 | $31,000 |
| MOATAZEDI DAVID | Aug 16, 2023 | Sell | 14,778 | $10.27 | $150,000 |
| Avelar Rui | Aug 16, 2023 | Sell | 2,211 | $10.27 | $23,000 |
| Beaver Sandra | Aug 16, 2023 | Sell | 2,211 | $10.27 | $23,000 |
| Malik Vikram | Aug 15, 2023 | Buy | 174,967 | $7.41 | $1.3M |
| MOATAZEDI DAVID | Mar 27, 2023 | Sell | 6,110 | $8.47 | $52,000 |
| MOATAZEDI DAVID | Mar 14, 2023 | Sell | 64,211 | $8.4689 | $540,000 |
| Avelar Rui | Mar 14, 2023 | Sell | 14,906 | $8.4689 | $130,000 |
| Alphaeon 1 LLC | Feb 17, 2023 | Sell | 1,850,000 | $8.4 | $16M |
| Medytox Inc. | Feb 7, 2023 | Sell | 2,187,511 | $8.5 | $19M |
| Medytox Inc. | Jan 20, 2023 | Sell | 37,043 | $11.04 | $410,000 |
What's the latest insider transaction for Evolus?
The most recent insider transaction for Evolus was conducted by Beaver Sandra, who sold 3,276 shares on September 6, 2024 at a price of $14.98 per share.
Which insider bought the most EOLS stock over the last two years?
Malik Vikram has bought the most EOLS stock in the last 2 years, with a total value of $1.3M.
Which insider has sold the most EOLS stock over the last two years?
Medytox Inc. has sold the most EOLS stock in the last 2 years, with a total value of $32M.
What is the total value of insider transactions for Evolus (EOLS) in the last 2 years?
The total value of insider transactions for Evolus in the last 2 years is negative, amounting to -$57M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Evolus' market confidence?
Over the last 2 years, insider transactions for Evolus have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
